Nasacort and Pharyngitis streptococcal - a phase IV clinical study of FDA data

Summary:

Pharyngitis streptococcal is reported as a side effect among people who take Nasacort (triamcinolone acetonide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Eliquis, and have Hypersensitivity.

The phase IV clinical study analyzes which people have Pharyngitis streptococcal when taking Nasacort. It is created by eHealthMe based on reports of 12,923 people who have side effects when taking Nasacort from the FDA, and is updated regularly.

What is Nasacort?

Nasacort has active ingredients of triamcinolone acetonide. It is often used in allergies. eHealthMe is studying from 13,298 Nasacort users. Check the latest studies of Nasacort.

What is Pharyngitis streptococcal?

Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus) is found to be associated with 731 drugs and 634 conditions by eHealthMe. Check the latest studies of Pharyngitis streptococcal.

On Aug, 06, 2026

12,923 people reported to have side effects when taking Nasacort.
Among them, 21 people (0.16%) have Pharyngitis streptococcal.

Could Nasacort cause Pharyngitis streptococcal?

Among these 21 people:

How long have people been on Nasacort when they have Pharyngitis streptococcal? *

What is the gender of people who have Pharyngitis streptococcal when taking Nasacort? *

female: 95.24 %
male: 4.76 %

What is the age of people who have Pharyngitis streptococcal when taking Nasacort? *

What are other drugs people take besides Nasacort? *

What are other side effects people have besides Pharyngitis streptococcal? *

Sinusitis (inflammation of sinus): 12 people, 57.14%
Nausea (feeling of having an urge to vomit): 10 people, 47.62%
Otitis (ear infection): 8 people, 38.10%
Headache (pain in head): 8 people, 38.10%
Dyspnea (difficult or laboured breathing): 7 people, 33.33%
Weight Decreased: 7 people, 33.33%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 6 people, 28.57%
Fever: 6 people, 28.57%
Back Pain: 6 people, 28.57%
Pneumonia: 6 people, 28.57%

What are the existing conditions these people have? *

Primary Immunodeficiency Syndrome: 8 people, 38.10%
Hypersensitivity: 8 people, 38.10%
Immunodeficiency Common Variable: 7 people, 33.33%
Cough: 5 people, 23.81%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 19.05%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 14.29%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 14.29%
High Blood Pressure: 3 people, 14.29%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 9.52%
Type 2 Diabetes: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Nasacort and have Pharyngitis streptococcal?

- Check whether Pharyngitis streptococcal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nasacort:

Nasacort (13,298 reports)

Browse all side effects of Nasacort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pharyngitis streptococcal:

Pharyngitis streptococcal (731 drugs)

Browse all the conditions that are associated with Pharyngitis streptococcal:

Pharyngitis streptococcal (634 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone acetonide (the active ingredients of Nasacort) and Nasacort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.